Bernstein Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,100
TD Cowen Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,050
Novo Nordisk's Ozempic Label Expansion Snags Approval From European Drug Regulator's Advisory Panel
Market Falls Thursday, Producer Inflation Grows, and Tech Pulls Back From Records | LiveStock
Telehealth Firm Ro Partners With Eli Lilly to Boost Access to Obesity Drug Zepbound
Eli Lilly Reports Positive Data From Late-Stage Breast Cancer Study
